ClearPoint Neuro, Inc.
CLPT
$10.64
$0.141.33%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 17.27% | 11.07% | 14.11% | 40.96% | 32.07% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 17.27% | 11.07% | 14.11% | 40.96% | 32.07% |
| Cost of Revenue | 27.49% | 7.68% | 7.58% | 31.58% | 1.63% |
| Gross Profit | 11.39% | 13.41% | 18.66% | 48.09% | 59.56% |
| SG&A Expenses | 12.36% | 29.43% | 15.94% | 16.77% | -0.90% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 18.38% | 23.56% | 16.14% | 24.72% | -3.81% |
| Operating Income | -20.24% | -46.18% | -19.08% | -5.62% | 33.75% |
| Income Before Tax | -32.30% | -45.44% | -16.61% | -3.43% | 37.71% |
| Income Tax Expenses | 66.67% | 20.00% | -- | -- | -- |
| Earnings from Continuing Operations | -32.42% | -45.34% | -16.61% | -3.43% | 37.49% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -32.42% | -45.34% | -16.61% | -3.43% | 37.49% |
| EBIT | -20.24% | -46.18% | -19.08% | -5.62% | 33.75% |
| EBITDA | -17.66% | -52.53% | -18.59% | -3.57% | 35.61% |
| EPS Basic | -28.72% | -33.46% | -4.05% | 7.63% | 44.06% |
| Normalized Basic EPS | -28.50% | -33.63% | -4.10% | 7.62% | 44.23% |
| EPS Diluted | -28.72% | -33.46% | -4.05% | 7.63% | 44.06% |
| Normalized Diluted EPS | -28.50% | -33.63% | -4.10% | 7.62% | 44.23% |
| Average Basic Shares Outstanding | 2.88% | 8.91% | 12.05% | 12.02% | 11.73% |
| Average Diluted Shares Outstanding | 2.88% | 8.91% | 12.05% | 12.02% | 11.73% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |